Trials / Not Yet Recruiting
Not Yet RecruitingNCT07137767
Quantitative Refractive Crosslinking in Presbyopia Aged Patients
Quantitative Refractive Crosslinking in Presbyopia-Aged Patients: An Open Label, Multi-center, Phase I Study of the TECLens Corneal Crosslinking System for Correction of Refractive Error in Patients of Presbyopia Age
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 25 (estimated)
- Sponsor
- TECLens, Inc. · Industry
- Sex
- All
- Age
- 40 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
An 'on-eye' UV delivery system for corneal crosslinking can be used safely and effectively to help free presbyopic patients from the need for reading glasses.
Detailed description
The clinical trial is evaluating the TECLens CXLens Crosslinking System, an investigational treatment using ultraviolet (UV) light (375 nm) with riboflavin (vitamin B2) to strengthen and reshape the cornea. By creating controlled biomechanical changes, this study aims to test whether the cornea can be reshaped to reduce refractive errors such as mild myopia or hyperopia in patients of presbyopic age.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Quantitative refractive crosslinking | Non-invasive corneal crosslinking device delivering controlled UV light through a contact lens platform for refractive reshaping of the cornea. |
Timeline
- Start date
- 2025-08-31
- Primary completion
- 2026-08-01
- Completion
- 2026-08-01
- First posted
- 2025-08-22
- Last updated
- 2025-08-29
Locations
2 sites across 2 countries: Brazil, Dominican Republic
Source: ClinicalTrials.gov record NCT07137767. Inclusion in this directory is not an endorsement.